Acute Deep Vein Thrombosis

Cardiovascular
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
FragminN/A1 trial
Active Trials
NCT00480636Completed102Est. Jun 2009
Penumbra
PenumbraALAMEDA, CA
1 program
Thrombolysis in combination with endhole aspirationN/A1 trial
Active Trials
NCT04297787CompletedEst. Jun 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PenumbraThrombolysis in combination with endhole aspiration
PfizerFragmin

Clinical Trials (2)

Total enrollment: 102 patients across 2 trials

NCT04297787PenumbraThrombolysis in combination with endhole aspiration

Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT

Start: Sep 2020Est. completion: Jun 2023
N/ACompleted

Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

Start: Jun 2007Est. completion: Jun 2009102 patients
N/ACompleted

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space